Fluaid
- Manufacturer
- PRINCE OF PEACE ENTERPRISES INC.
- Effective date
- 2014-04-01
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 5
- Source
- full-release
- Hydrated at
- 2026-05-31 22:39:06
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients Purpose
Menthol 135 mg.................Oral Pain Reliever
OTC - PURPOSE SECTION
Uses For the temporary relief of sore throat
OTC - WHEN USING SECTION
When using this product
- Do not exceed recommended dosage
OTC - ASK DOCTOR/PHARMACIST SECTION
Stop use and ask a doctor if
- sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, swelling, nausea, or vomiting
- sore mouth symptoms do not improve in 7 days
- irritation, pain, or redness persists or worsens
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep this and all drugs out of reach of children.
OTC - DO NOT USE SECTION
Do not use otherwise than as directed
WARNINGS SECTION
In the case of accidental overdose, seek professional assistance or contact a poison control center immediately.
OTC - QUESTIONS SECTION
- Questions? 1-510-887-1899 Monday to Friday, 8 am - 5 pm Pacific Standard Time
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
INDICATIONS & USAGE SECTION
UsesFor the temporary relief of sore throat
DOSAGE & ADMINISTRATION SECTION
Directions
| Adults and children 12 years of age and older | Place 1 bags in 6 oz of boiling water and stir. Allow liquid to cool, Drink up to 4 times daily or as directed by a doctor |
| Children under 12 years of age | Ask A doctor |
INACTIVE INGREDIENT SECTION
Corydalis bungeana, Phragmites Root, Kudzu Root, Siler Root, Schizonepeta Flower, Lactose, Fragrant Angelica Root, Platycodon Root, Bupleurum Root, Perilla Leaf, and Apricot Seed
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62003-002-30 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-33bd-60a7-e053-dbdaa90a05bd | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62003-002-30 | Fluaid | 3 g in 1 PACKET | GRANULE, FOR SOLUTION | 3 | 5 | |
| 62003-002-30 | Fluaid | 10 in 1 BOX | GRANULE, FOR SOLUTION | 10 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Menthol | ACTIVE INGREDIENT | L7T10EIP3A | 5 | |
| Menthol | ACTIVE MOIETY | L7T10EIP3A | 5 | |
| Angelica dahurica root | INACTIVE INGREDIENT | 1V63N2S972 | 5 | |
| APRICOT | INACTIVE INGREDIENT | 269CJD5GZ9 | 5 | |
| Bupleurum chinense root | INACTIVE INGREDIENT | BMA22623YK | 5 | |
| CORYDALIS BUNGEANA FLOWERING/FRUITING TOP | INACTIVE INGREDIENT | 93W3R296YH | 5 | |
| Lactose | INACTIVE INGREDIENT | J2B2A4N98G | 5 | |
| Perilla frutescens leaf | INACTIVE INGREDIENT | T4L5881Y68 | 5 | |
| PHRAGMITES AUSTRALIS ROOT | INACTIVE INGREDIENT | BBJ7AOM815 | 5 | |
| PLATYCODON GRANDIFLORUM LEAF | INACTIVE INGREDIENT | 2L64H2X8DY | 5 | |
| PUERARIA MONTANA VAR. CHINENSIS ROOT | INACTIVE INGREDIENT | FQN0D1U235 | 5 | |
| Saposhnikovia divaricata root | INACTIVE INGREDIENT | 8H84LFK2QD | 5 | |
| SCHIZONEPETA TENUFOLIA SPIKE | INACTIVE INGREDIENT | 2FN3BA1MZE | 5 |
Products#
Every source-derived product name is available through these pages.
- Fluaid
- menthol
- Angelica dahurica root
- Lactose
- Bupleurum chinense root
- APRICOT
- PUERARIA MONTANA VAR. CHINENSIS ROOT
- Saposhnikovia divaricata root
- SCHIZONEPETA TENUFOLIA SPIKE
- PLATYCODON GRANDIFLORUM LEAF
- Perilla frutescens leaf
- CORYDALIS BUNGEANA FLOWERING/FRUITING TOP
- PHRAGMITES AUSTRALIS ROOT
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62003-002 | 62003-002-30 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Lactose | LACTOSE | J2B2A4N98G | TABLET, CHEWABLE / ORAL | 1412 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | SOLUTION / ORAL | 1682 mg/15ml | ||
| Lactose | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 133 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Lactose | LACTOSE | J2B2A4N98G | GRANULE, FOR SUSPENSION / ORAL | 512.5 mg/5ml | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET, EXTENDED RELEASE / ORAL | 400 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 133 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | POWDER / VAGINAL | 430 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET, SUGAR COATED / ORAL | NA | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET / SUBLINGUAL | 352 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | CREAM / VAGINAL | 3 %w/w | ||
| Lactose | LACTOSE | J2B2A4N98G | FILM, EXTENDED RELEASE / TRANSDERMAL | 675 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET, COATED / ORAL | 332.05 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET, FILM COATED / ORAL | 590 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | OINTMENT / TOPICAL | NA | ||
| Lactose | LACTOSE | J2B2A4N98G | CAPSULE, COATED PELLETS / ORAL | 135.2 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | CAPSULE / ORAL | 530 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | SOLUTION / RECTAL | 8 %w/v | ||
| Lactose | LACTOSE | J2B2A4N98G | POWDER / RESPIRATORY (INHALATION) | 90 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET / RECTAL | 20 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | INJECTION / INTRAMUSCULAR | 203.5 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | 193.8 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | CAPSULE / RESPIRATORY (INHALATION) | 44.4 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | INJECTION, SOLUTION / INTRAVENOUS | 0.45 %w/v | ||
| Lactose | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 133 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 620 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET, DELAYED RELEASE / ORAL | 160 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | SUPPOSITORY / VAGINAL | NA | ||
| Lactose | LACTOSE | J2B2A4N98G | CAPSULE, DELAYED RELEASE / ORAL | 231.84 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | POWDER, FOR SOLUTION / ORAL | NA | ||
| Lactose | LACTOSE | J2B2A4N98G | CONCENTRATE / ORAL | NA | ||
| Lactose | LACTOSE | J2B2A4N98G | INJECTION / INTRAVENOUS | 203.5 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET, EFFERVESCENT / ORAL | 96.5 mg | ||
| Lactose | LACTOSE | J2B2A4N98G | TABLET / BUCCAL | 296.7 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 7dc7752a-ef40-40c3-8571-c8b1d6162469 | b0c115b5-58f6-4b5f-be00-c0bd9ac7f138 | 2014-04-01 | Warnings | 7dc7752a-ef40-40c3-8571-c8b1d6162469 b0c115b5-58f6-4b5f-be00-c0bd9ac7f138 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
